Current evidence links human obesity to ECS activation, increased endocannabinoid levels in both central and peripheral tissues, along with cannabinoid receptor type 1 (CBR1) up‐regulation. This evidence concerns the gene CBR1 and obesity due to melanocortin 4 receptor deficiency.